JAK–STAT signaling pathway component (JAK–STAT (for pathway as whole; specific members: JAK1, JAK2, JAK3, TYK2, STAT1, STAT2, etc.))

The JAK–STAT signaling pathway is a cascade of protein interactions crucial for transmitting signals from extracellular cytokines and growth factors, through cell surface receptors and Janus kinases (JAKs), to signal transducers and activators of transcription (STATs), which regulate gene expression in the nucleus. Key components include four JAK kinases (JAK1, JAK2, JAK3, TYK2), seven STAT proteins (STAT1, STAT2, STAT3, STAT4, STAT5A, STAT5B, STAT6), and diverse cytokine receptors. JAK–STAT signaling controls key biological processes such as immune function, cell growth, survival, differentiation, and apoptosis. Dysregulation is implicated in cancer, autoimmune diseases, hematopoietic disorders, and inflammatory conditions. Numerous drugs target this pathway, notably by inhibiting JAK kinases[1][2][3][4][5][6]. Note: “JAK–STAT signaling pathway components” refers to a broad collection of molecular entities (JAKs, STATs, receptors), not a single, specific molecule, gene, or protein. For purposes requiring structured data about therapeutic targets, it is preferable to query individual components such as “Janus kinase 1 (JAK1)” or “Signal transducer and activator of transcription 3 (STAT3)”, as these are canonical molecular targets. Marking is_incorrect true due to the referent being a pathway or group, not a discrete drug target[1][2][3].

Other names

Janus kinase–signal transducer and activator of transcription pathway componentJAK/STAT pathway componentJAK kinaseSTAT proteinJAK kinasesSTATs

Inhibition of tyrosine kinase activity (JAK inhibitor) Blockade of STAT phosphorylation and dimerization Suppression of transcriptional activation of pro-inflammatory and proliferative genes